111 related articles for article (PubMed ID: 21965787)
1. Vitamin D in colorectal, breast, prostate and lung cancer: a pilot study.
Pazdiora P; Svobodova S; Fuchsova R; Kucera R; Prazakova M; Vrzalova J; Narsanska A; Strakova M; Treskova I; Pecen L; Treska V; Holubec L; Pesek M; Finek J; Topolcan O
Anticancer Res; 2011 Oct; 31(10):3619-21. PubMed ID: 21965787
[TBL] [Abstract][Full Text] [Related]
2. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
[TBL] [Abstract][Full Text] [Related]
3. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States).
Giovannucci E
Cancer Causes Control; 2005 Mar; 16(2):83-95. PubMed ID: 15868450
[TBL] [Abstract][Full Text] [Related]
4. Are patients with skin cancer at lower risk of developing colorectal or breast cancer?
Soerjomataram I; Louwman WJ; Lemmens VE; Coebergh JW; de Vries E
Am J Epidemiol; 2008 Jun; 167(12):1421-9. PubMed ID: 18424428
[TBL] [Abstract][Full Text] [Related]
5. Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk.
Peters U; Hayes RB; Chatterjee N; Shao W; Schoen RE; Pinsky P; Hollis BW; McGlynn KA;
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):546-52. PubMed ID: 15066918
[TBL] [Abstract][Full Text] [Related]
6. A critical review of studies on vitamin D in relation to colorectal cancer.
Grant WB; Garland CF
Nutr Cancer; 2004; 48(2):115-23. PubMed ID: 15231446
[TBL] [Abstract][Full Text] [Related]
7. Alpha-1 antitrypsin (alpha1-AT) plasma levels in lung, prostate and breast cancer patients.
El-Akawi ZJ; Al-Hindawi FK; Bashir NA
Neuro Endocrinol Lett; 2008 Aug; 29(4):482-4. PubMed ID: 18766166
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D status and the risk of lung cancer: a cohort study in Finland.
Kilkkinen A; Knekt P; Heliövaara M; Rissanen H; Marniemi J; Hakulinen T; Aromaa A
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3274-8. PubMed ID: 18990771
[TBL] [Abstract][Full Text] [Related]
9. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer.
Gann PH; Ma J; Hennekens CH; Hollis BW; Haddad JG; Stampfer MJ
Cancer Epidemiol Biomarkers Prev; 1996 Feb; 5(2):121-6. PubMed ID: 8850273
[TBL] [Abstract][Full Text] [Related]
10. Monocyte tissue factor levels in cancer patients.
Lwaleed BA; Francis JL; Chisholm M
Saudi Med J; 2000 Aug; 21(8):722-9. PubMed ID: 11423883
[TBL] [Abstract][Full Text] [Related]
11. The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial.
Goodman GE; Schaffer S; Omenn GS; Chen C; King I
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):518-26. PubMed ID: 12814997
[TBL] [Abstract][Full Text] [Related]
12. Thyroid function and cancer risk: a prospective population study.
Hellevik AI; Asvold BO; Bjøro T; Romundstad PR; Nilsen TI; Vatten LJ
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):570-4. PubMed ID: 19155436
[TBL] [Abstract][Full Text] [Related]
13. Activity of cancer procoagulant (CP) in serum of patients with cancer of lung, breast, oesophagus and colorectum.
Rucińska M; Furman M; Skrzydlewski Z; Zaremba E
Acta Biochim Pol; 1997; 44(1):109-12. PubMed ID: 9241361
[TBL] [Abstract][Full Text] [Related]
14. Interaction of factors related to the metabolic syndrome and vitamin D on risk of prostate cancer.
Tuohimaa P; Tenkanen L; Syvälä H; Lumme S; Hakulinen T; Dillner J; Hakama M
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):302-7. PubMed ID: 17301263
[TBL] [Abstract][Full Text] [Related]
15. Fat soluble vitamins and cancer localization associated to an abnormal ketone derivative of D3 vitamin: carcinomedin.
Rougereau A; Person O; Rougereau G
Int J Vitam Nutr Res; 1987; 57(4):367-73. PubMed ID: 3440711
[TBL] [Abstract][Full Text] [Related]
16. Obesity and increased risk of cancer: does decrease of serum 25-hydroxyvitamin D level with increasing body mass index explain some of the association?
Lagunova Z; Porojnicu AC; Grant WB; Bruland Ø; Moan JE
Mol Nutr Food Res; 2010 Aug; 54(8):1127-33. PubMed ID: 20512788
[TBL] [Abstract][Full Text] [Related]
17. Folate levels and cancer morbidity and mortality: prospective cohort study from Busselton, Western Australia.
Rossi E; Hung J; Beilby JP; Knuiman MW; Divitini ML; Bartholomew H
Ann Epidemiol; 2006 Mar; 16(3):206-12. PubMed ID: 16343942
[TBL] [Abstract][Full Text] [Related]
18. Predictors of serum selenium in cigarette smokers and the lack of association with lung and prostate cancer risk.
Goodman GE; Schaffer S; Bankson DD; Hughes MP; Omenn GS;
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1069-76. PubMed ID: 11588133
[TBL] [Abstract][Full Text] [Related]
19. Dietary calcium, vitamin D, and the risk of colorectal cancer in Stockholm, Sweden.
Pritchard RS; Baron JA; Gerhardsson de Verdier M
Cancer Epidemiol Biomarkers Prev; 1996 Nov; 5(11):897-900. PubMed ID: 8922297
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of vitamin D deficiency in type 1 diabetes mellitus and healthy children.
Bener A; Alsaied A; Al-Ali M; Al-Kubaisi A; Basha B; Abraham A; Guiter G; Mian M
Acta Diabetol; 2009 Sep; 46(3):183-9. PubMed ID: 18846317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
